PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on
/PRNewswire/ GenScript ProBio, a leading Biologics CDMO to the bio-pharmaceutical market, and Bio Immunitas, a UK pharmaceutical company with a novel, safe.